Seeing Is Believing
FULC is currently covered by 8 analysts with an average price target of $6.36. This is a potential upside of $1.81 (39.78%) from yesterday's end of day stock price of $4.55.
Fulcrum Therapeutics's activity chart (see below) currently has 53 price targets and 68 ratings on display. The stock rating distribution of FULC is 71.88% BUY, 21.88% HOLD and 6.25% SELL.
Analysts average stock forecasts to be materialized ratio is 55.14% with an average time for these price targets to be met of 163.5 days.
Highest price target for FULC is $15, Lowest price target is $2, average price target is $6.36.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 14-Nov-2024. First documented stock forecast 12-Aug-2019.
Currently out of the existing stock ratings of FULC, 23 are a BUY (71.88%), 7 are a HOLD (21.88%), 2 are a SELL (6.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4
$-0.35 (-8.05%)
$4
1 months 11 days ago
(14-Nov-2024)
10/17 (58.82%)
$0.64 (19.05%)
135
Buy
$3
$-1.35 (-31.03%)
$11
3 months 13 days ago
(12-Sep-2024)
4/6 (66.67%)
$-0.44 (-12.79%)
199
Hold
$2
$-2.35 (-54.02%)
$10
3 months 13 days ago
(12-Sep-2024)
9/11 (81.82%)
$-1.44 (-41.86%)
72
Buy
$14
$9.65 (221.84%)
$16
7 months 11 days ago
(14-May-2024)
0/6 (0%)
$6.09 (76.99%)
Buy
$15
$10.65 (244.83%)
$21
9 months 27 days ago
(28-Feb-2024)
3/10 (30%)
$4.68 (45.35%)
170
What is FULC (Fulcrum Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FULC (Fulcrum Therapeutics) with a proven track record?
Which analyst has the current lower performing score on FULC (Fulcrum Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FULC (Fulcrum Therapeutics)?
Which analyst is the currently most bullish on FULC (Fulcrum Therapeutics)?
Which analyst is the currently most reserved on FULC (Fulcrum Therapeutics)?